Introducing SEMPHN’s CEO: Quinn Pawson

Plural Agency • February 3, 2022
The SEMPHN Board and Staff welcomed Quinn Pawson as SEMPHN’s new Chief Executive Officer on 31 January 2022. 

Quinn is an experienced CEO and executive in the not for profit sector with a strong track record in successfully leading innovation, cultural transformation, mergers and reorganisations. He is adept at maximising results and services for individuals, families and communities disadvantaged by mental health, homelessness, poverty, and family violence.

Quinn’s most recent role was Chief Executive Officer at VincentCare Victoria and VincentCare Community Housing. He has also held executive roles at Uniting Vic/Tas, Prahran Mission and Relationships Australia.

Quinn is focused on creating a safe, inclusive, and supporting culture with a leadership style that engages the heart, head and soul of the organisation. He is passionate about growing and aligning values, people, culture, systems and financial capital in service of an organisation’s purpose.

Get to know other key figures at SEMPHN, including our Board, Community and Clinical Council members and our Executive Leadership Team on the ‘About Us’ page.

Latest news

Mental Health & Better Access Quality Improvement - Activity 4

July 23, 2026
The purpose of this activity is to ensure that patients with an active Mental Health Treatment Plan who have not attended the practice in the last six months are identified and followed up, supporting continuity of care and improved mental health outcomes.

Childhood immunisation – one more way to keep them safe

July 15, 2026
Recommendations from healthcare professionals play an important role in parents/guardians’ decisions about childhood vaccination. These recommendations are informed by the National Immunisation Program (NIP) schedule, which outlines the vaccinations recommended for all children in Australia.

Free Respiratory Syncytial Virus vaccine available for eligible pregnant women

July 9, 2026
A free vaccine to help protect babies against Respiratory Syncytial Virus (RSV) is available for eligible pregnant women in Australia.